| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
T69625-5mg买3赠1 |
98.40% | ￥390.00 |
5 | - | - | - | - |
|
T69625-10mg买3赠1 |
98.40% | ￥590.00 |
7 | - | - | - | - |
|
T69625-25mg买3赠1 |
98.40% | ￥1180.00 |
5 | - | - | - | - |
|
T69625-50mg |
98% | ￥1980.00 |
货期：2-3天 | - | - | - | - |
|
T69625-100mg |
98% | ￥3460.00 |
货期：2-3天 | - | - | - | - |
|
| 产品描述： | Ipsapirone, also known as BAY q 7821, is a new pyrimidinylpiperazine ligand potent and specific for 5-HT1A receptors. Ipsapirone hydrochloride has potential therapeutic use in affective disorders. |
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶点： | 5-HT1A Receptor | ||||||||||||||||||||
| 体外研究： | Ipsapirone inhibits induced by 8-OH-DPAT and 5-methoxydimethyltryptamine (agonists of 5-HT1A receptors) behavioural effects (flat body posture and forepaw treading) in normal and reserpinized rats. Ipsapirone (2.5-80 mg/kg), given alone to rats induces a slight flattening of body posture (~ 1 point at the highest dose) and a mild hind limb abduction observed at doses 2.5-80 mg/kg. Ipsapirone given alone at low doses (2.5-10 mg/kg i.p.) does not significantly change the body temperature in rats and mice, but decreased it in both those species at high doses (35 mg/kg i.p.) by ca. 2-2.5℃. |
||||||||||||||||||||
| 体内研究： | Ipsapirone inhibits induced by 8-OH-DPAT and 5-methoxydimethyltryptamine (agonists of 5-HT1A receptors) behavioural effects (flat body posture and forepaw treading) in normal and reserpinized rats. Ipsapirone (2.5-80 mg/kg), given alone to rats induces a slight flattening of body posture (~ 1 point at the highest dose) and a mild hind limb abduction observed at doses 2.5-80 mg/kg. Ipsapirone given alone at low doses (2.5-10 mg/kg i.p.) does not significantly change the body temperature in rats and mice, but decreased it in both those species at high doses (35 mg/kg i.p.) by ca. 2-2.5℃. |
||||||||||||||||||||
| 参考文献： | 1: Johansen FF, Hasseldam H, Nybro Smith M, Rasmussen RS. Drug-induced hypothermia by 5HT1A agonists provide neuroprotection in experimental stroke: new perspectives for acute patient treatment. J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2879-87. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.019. Epub 2014 Oct 11. Review. PubMed PMID: 25307429. 2: Kishi T, Meltzer HY, Matsuda Y, Iwata N. Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: systematic review and meta-analysis. Psychol Med. 2014 Aug;44(11):2255-69. doi: 10.1017/S0033291713002857. Epub 2013 Nov 21. Review. PubMed PMID: 24262766. 3: Fox MA, Andrews AM, Wendland JR, Lesch KP, Holmes A, Murphy DL. A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology (Berl). 2007 Dec;195(2):147-66. Epub 2007 Aug 22. Review. PubMed PMID: 17712549. 4: Chessick CA, Allen MH, Thase M, Batista Miralha da Cunha AB, Kapczinski FF, de Lima MS, dos Santos Souza JJ. Azapirones for generalized anxiety disorder. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006115. Review. PubMed PMID: 16856115. 5: de Boer SF, Koolhaas JM. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. Eur J Pharmacol. 2005 Dec 5;526(1-3):125-39. Epub 2005 Nov 28. Review. PubMed PMID: 16310183. |
||||||||||||||||||||
| 保存条件： | -20℃ | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京